A. Schultheis

发表

Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights.

J. Reis-Filho, B. Weigelt, F. Bidard, 2015, Journal of the National Cancer Institute.

Molecular determinants of irinotecan efficacy

H. Lenz, K. Danenberg, W. Fazzone, 2006, International journal of cancer.

The Birth of an Adenoid Cystic Carcinoma

J. Reis-Filho, B. Weigelt, S. Badve, 2015, International journal of surgical pathology.

TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers

Jorge S Reis-Filho, J. Reis-Filho, B. Weigelt, 2016, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas

T. Buhl, J. Wolf, S. Perner, 2015, International journal of cancer.

Precision Medicine in Non-Small Cell Lung Cancer: Current Applications and Future Directions.

M. Ladanyi, D. Mandelker, Soo-Ryum Yang, 2020, Seminars in cancer biology.

Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer

Alexandra Pohl, Dongyun Yang, Hatim Husain, 2009, Pharmacogenetics and genomics.

The impact of sequencing on diagnosis and treatment of malignant melanoma

R. Büttner, C. Mauch, S. Merkelbach-Bruse, 2016, Expert review of molecular diagnostics.

Radioiodine Refractory Follicular Thyroid Cancer and Surgery for Cervical Relapse

A. Schultheis, C. Bruns, H. Alakus, 2021, Cancers.

[Effectiveness of radiofrequency ablation of lung tumours ].

F. Sommerer, A. Tannapfel, R. Kappes, 2008, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

Lymphatic Vessel Invasion in Routine Pathology Reports of Papillary Thyroid Cancer

A. Schultheis, C. Bruns, H. Alakus, 2022, Frontiers in Medicine.

Combined Targeted Resequencing of Cytosine DNA Methylation and Mutations of DNA Repair Genes with Potential Use for Poly(ADP-Ribose) Polymerase 1 Inhibitor Sensitivity Testing.

R. Herwig, B. Hennessy, R. Buettner, 2019, The Journal of molecular diagnostics : JMD.

Clinicopathological Characteristics of RET Rearranged Lung Cancer in European Patients

L. Bubendorf, R. Hein, W. Engel-Riedel, 2016, Journal of Thoracic Oncology.

ABCB1, SLCO1B1 and UGT1A1 Gene Polymorphisms Are Associated with Toxicity Line Irinotecan

H. Lenz, W. Fazzone, R. Ladner, 2007 .

ABCB1, SLCO1B1 and UGT1A1 gene polymorphisms are associated with toxicity in metastatic colorectal cancer patients treated with first-line irinotecan.

H. Lenz, W. Fazzone, R. Ladner, 2007, Drug metabolism letters.

Salvage surgery for cervical radioiodine refractory 18F-FDG-PET positive recurrence of papillary thyroid cancer

A. Schultheis, H. Alakus, M. Schmidt, 2021, Endocrine connections.

Genetic Heterogeneity of MET-aberrant Non-Small Cell Lung Cancer and its Impact on the Outcome of Immunotherapy.

N. Reinmuth, J. Panse, J. Wolf, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Comparison of in situ and extraction-based methods for the detection of MET amplifications in solid tumors

R. Büttner, S. Merkelbach-Bruse, A. Schultheis, 2019, Computational and structural biotechnology journal.

Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases

J. Reis-Filho, B. Weigelt, P. Nuciforo, 2018, Oncotarget.

Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy.

V. Reuter, I. Ostrovnaya, B. Weigelt, 2022, Clinical genitourinary cancer.

Leiomyoma With Bizarre Nuclei: A Morphological, Immunohistochemical and Molecular Analysis of 31 Cases

V. Reuter, B. Weigelt, Yingbei Chen, 2017, Modern Pathology.

Hürthle Cell Carcinoma: Single Center Analysis and Considerations for Surgical Management Based on the Recent Literature

A. Schultheis, C. Bruns, H. Alakus, 2022, Frontiers in Endocrinology.

Two immunoglobulin G fragment C receptor polymorphisms associated with clinical outcome of EGFR-expressing metastatic colorectal cancer patients treated with single agent cetuximab.

H. Lenz, W. Zhang, D. Yang, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab

A. Oza, D. Gandara, H. Hirte, 2008, Clinical Cancer Research.

ALKG1269A mutation as a potential mechanism of acquired resistance to crizotinib in an ALK-rearranged inflammatory myofibroblastic tumor

J. Wolf, M. Puesken, R. Büttner, 2017, npj Precision Oncology.

Preoperative biopsies as predictor for the necessity of inguinal lymph node surgery in squamous cell carcinoma of the vulva-a retrospective tertiary center analysis

A. Schultheis, P. Mallmann, F. Thangarajah, 2020, Journal of Cancer Research and Clinical Oncology.

[Minimally invasive follicular thyroid carcinoma : Not always total thyroidectomy].

A. Schultheis, M. Hermann, F. Kober, 2010, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

Analysis of topographical distribution of prostate cancer and related pathological findings in prostatectomy specimens using cMDX document architecture

Okyaz Eminaga, Olaf Bettendorf, Elke Eltze, 2016, J. Biomed. Informatics.

ROS1 rearrangement in non-small cell lung cancer (NSCLC): Prognostic and predicitve impact and genetic variability.

Y. Ko, J. Wolf, R. Rosell, 2015 .

PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).

H. Groen, M. Hellmich, Roman K. Thomas, 2014 .

Block Excision of Iridociliary Tumors Enables Molecular Profiling and Immune Vaccination.

R. Büttner, G. Schuler, C. Cursiefen, 2017, Ophthalmology.

Strong ERG Positivity in Papillary Intralymphatic Angioendothelioma of the Testis of a 24-Year-Old Male: A Case Report

S. Steurer, A. Schultheis, M. Sandmann, 2013, Case reports in pathology.

[Excision and tectonic covering of a vascular leiomyoma of the ciliary body with large anterior staphyloma using scleral patch graft].

N. Bornfeld, C. Cursiefen, L. Heindl, 2020, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[Surgical revision of the pilonidal sinus with single shot antibiosis].

A. Schultheis, W. Duesel, H. Bunke, 1995, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

A Survey of DICER1 Hotspot Mutations in Ovarian and Testicular Sex Cord-Stromal Tumors

V. Reuter, B. Weigelt, E. Oliva, 2015, Modern Pathology.

The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans.

George Kollias, John F Smyth, Toby Lawrence, 2009, The Journal of clinical investigation.

FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.

S. Groshen, H. Lenz, H. Chang, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas

I. Ellis, S. Chandarlapaty, J. Palazzo, 2018, Nature Communications.

The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis‐generating study

I. Ellis, J. Reis-Filho, L. Norton, 2015, The Journal of pathology.

Clinical impact of PD-L1 and PD-1 expression in squamous cell cancer of the vulva

R. Buettner, S. Hamacher, A. Schultheis, 2019, Journal of Cancer Research and Clinical Oncology.

PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations

H. Groen, M. Hellmich, T. Zander, 2016, Oncoimmunology.

The genetic landscape of breast carcinomas with neuroendocrine differentiation

J. Reis-Filho, L. Norton, B. Weigelt, 2017, The Journal of pathology.

Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer

I. Ellis, J. Reis-Filho, A. Vincent-Salomon, 2016, Modern Pathology.

Uterine adenosarcomas are mesenchymal neoplasms

J. Reis-Filho, D. Levine, B. Weigelt, 2016, The Journal of pathology.

Genomic landscape of adenoid cystic carcinoma of the breast

O. Mariani, J. Reis-Filho, L. Norton, 2015, The Journal of pathology.

Ampli fi cation Status in Therapy-Naïve Adeno-and Squamous Cell Carcinomas of the Lung

T. Zander, Y. Ko, K. Hekmat, 2015 .

MET Amplification Status in Therapy-Naïve Adeno- and Squamous Cell Carcinomas of the Lung

T. Zander, Y. Ko, K. Hekmat, 2014, Clinical Cancer Research.

MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast

Melissa P. Murray, J. Reis-Filho, B. Weigelt, 2015, Histopathology.

Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers

G. Croci, U. Malapelle, E. Rijavec, 2019, International journal of molecular sciences.

Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular Pathogenesis

B. Weigelt, M. Hameed, D. DeLair, 2017, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogies

J. Wolf, R. Buettner, H. Reinhardt, 2018, Modern Pathology.

Comparison of in Situ and Extraction-Based Methods for the Detection of ROS1 Rearrangements in Solid Tumors.

R. Riedel, J. Wolf, R. Buettner, 2019, Journal of Molecular Diagnostics.

ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability

C. Kropf-Sanchen, Y. Ko, J. Wolf, 2015, Oncotarget.

Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small-cell lung cancer

J. Wolf, R. Büttner, H. Schildhaus, 2014, Modern Pathology.

Comparison of Blood Collection Tubes from Three Different Manufacturers for the Collection of Cell-Free DNA for Liquid Biopsy Mutation Testing.

R. Büttner, S. Merkelbach-Bruse, J. Fassunke, 2017, The Journal of molecular diagnostics : JMD.

Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer.

S. Groshen, H. Lenz, W. Zhang, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

PD-L1 expression in small cell neuroendocrine carcinomas.

Roman K. Thomas, T. Zander, J. Wolf, 2015, European journal of cancer.

Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.

A. Viale, J. Reis-Filho, B. Weigelt, 2015, Journal of the National Cancer Institute.

Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer

Roman K. Thomas, T. Zander, D. Seidel, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Genetic analysis of a morphologically heterogeneous ovarian endometrioid carcinoma

J. Reis-Filho, B. Weigelt, R. Lim, 2017, Histopathology.

Cystic Lesions of the Pancreas - Expect the Unexpected: Co-Occurence of a Mixed Duct-Type Pancreaticobiliary IPMN and a Microcystic Serous Cystadenoma - A Case Report

A. Quaas, R. Büttner, T. Persigehl, 2020, Annals of Case Reports.

PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups

E. Wardelmann, W. Berdel, C. Müller-Tidow, 2015, PloS one.

Lung cancer. Molecular pathology and personalized therapy

J. Wolf, R. Büttner, A. Schultheis, 2013 .

Adrenal Surgery in the Era of Multidisciplinary Endocrine Tumor Boards.

R. Wahba, A. Schultheis, H. Alakus, 2022, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Genetic instability and recurrent MYC amplification in ALK‐translocated NSCLC: a central role of TP53 mutations

J. Wolf, Sandra Frank, R. Buettner, 2018, The Journal of pathology.

Spatial Tumor Heterogeneity in Lung Cancer with Acquired Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance: Targeting High-Level MET-Amplification and EGFR T790M Mutation Occurring at Different Sites in the Same Patient.

Roman K. Thomas, F. Leenders, J. Wolf, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Could Negative Tc-99m-Methoxyisobutylisonitrile (MIBI) Scintigraphy Obviate the Need for Surgery for Bethesda III and IV Thyroid Nodules?

A. Schultheis, C. Chiapponi, M. Engels, 2021, Surgeries.

Genomic characterization of small cell carcinomas of the uterine cervix

J. Reis-Filho, B. Weigelt, E. Wardelmann, 2021, Molecular oncology.

Advance of theragnosis biomarkers in lung cancer: from clinical to molecular pathology and biology.

J. Wolf, R. Buettner, A. Schultheis, 2019, Journal of thoracic disease.

[Application of FISH in the diagnosis of lung cancer].

A. Schultheis, Lena Hieggelke, 2020, Der Pathologe.

RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers.

J. Reis-Filho, B. Weigelt, C. Lemetre, 2016, European journal of cancer.

Polymorphisms in angiogenesis related genes predict clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with first line 5-FU or capecitabine in combination with oxaliplatin and bevacizumab (FOLFOX/BV or XELOX/BV)

H. Lenz, H. Chang, D. Yang, 2007 .